The 2024 Academy of Managed Care Pharmacy (AMCP) Nexus conference from Oct. 14–17 gathers more than 2,500 managed care leaders to Las Vegas, Nevada, to discuss some of the most complex issues facing the health care industry. Here is a roundup of Prime's award-winning presentations, research, insights and perspectives from the event. This will be refreshed regularly to include the latest updates from the event. 

---

Event  

Prime presents at AMCP Nexus 2024 on Oct. 14–17
Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.
Read more »
 

Press release

Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more
Read more »
 

Perspectives

A preview of Prime Therapeutics’ presence at AMCP Nexus 2024
Pat Gleason, assistant vice president, health outcomes, and David Eckwright, senior director, clinical project and program management, share an overview of Prime’s data and insights slated for this week
Read more »

AMCP Nexus 2024 in focus: Research shows translation services improve health equity for Medicare members 
Nicole Grevenitz, director of clinical account services, shares more from the research study “Promoting Health Equity Through Enhanced, Personalized Digital Outreach” 
Read more »

AMCP Nexus 2024 in focus: New research offers insight into use of faricimab-svoa (Vabysmo^®) therapy for retinal diseases
Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) New to Faricimab-svoa Therapy” 
Read more »

AMCP Nexus 2024 in focus: How Prime’s utilization management strategies improve cost savings for immunoglobulin replacement therapy 
Lead authors Erin Ventura and Alina Liang share more about the study “Evaluating the 10-Year Impact of an Immunoglobulin Utilization Management and Dose Optimization Program in the Managed Care Setting”
Read more »

AMCP Nexus 2024 in focus: Research details impact of gene therapy treatment for spinal muscular atrophy
Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”
Read more »

AMCP Nexus 2024 in focus: How social determinants of health data can be used to better treat patients with diabetes
Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A Latent Profile Analysis”
Read more »

AMCP Nexus 2024 in focus: Student session seeks to decode cell and gene therapy
Prime's Sneha Sharma and MichaelSzatkowski present “A beginner’s guide to decoding cell and gene therapy” educational session at event in Las Vegas, Nevada
Read more »

AMCP Nexus 2024 in focus: Strategies for managing complex eye conditions
Experts share insights in “The evolving strategies for managing nAMD and DME” session at Las Vegas event
Read more »

AMCP Nexus 2024 in focus: Experts share how to improve Medicare Star measures using real-world insights
Prime’s Sean Wuest and Highmark Health’s Lisanne Holley present educational session at Las Vegas event
Read more »

AMCP Nexus 2024 in focus: Exploring drug cost savings through HighTouchRx^®
Nick Friedlander, clinical program pharmacist at Prime, shares more about two research studies that convey the impact of one cost-savings solution
Read more »

AMCP Nexus 2024 in focus: Managed care expert shares what’s next for retiring professionals
Prime's Madhavi Manduru-Rao presents “Navigating the Final Chapter: What’s Next for Your Managed Care Pharmacy Career Journey – Opportunity for Rewirement vs. Retirement”
Read more »

AMCP Nexus 2024 in focus: New study uses social determinants of health to better treat patients with chronic lung conditions
Lead author Kristin Brown-Gentry shares insights from the study “Unlocking Public Health Insights: Leveraging Air Quality Data to Develop Social Determinants of Health Metrics Linked to Asthma Medication Ratio”
Read more »

AMCP Nexus 2024 in focus: Identifying a meaningful comparison using propensity score weighting
Brooke Hunter, senior health outcomes scientist at Prime, shares more about the study “Methodological Framework for Propensity Adjusted Benchmarks for Pharmacy Key Performance Indicators”
Read more »

AMCP Nexus 2024 in focus: Prime presents keynote “Specialty Pharmaceuticals in Development”
For the first time, Prime Therapeutics hosted the AMCP Nexus specialty keynote, addressing trends in cell and gene therapy and rare disease and immunology categories
Read more »

 

In the news

Humira Biosimilars Got Off to a Slow Start. Has That Changed? | AMCP Nexus 2024
Managed Healthcare Executive: Large PBMs are removing Humira from some of their formularies. AMCP Nexus panelists still see challenges and a need for education and more attention to patient interests.
Read more »

In the Real World, People Do Not Stick With GLP-1s for Weight Loss | AMCP Nexus 2024
Managed Healthcare Executive: Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years later according to Prime Therapeutics’ real-world evidence, says Ben Urick, Pharm.D., Ph.D., a health outcomes researcher for the pharmacy benefit manager.
Read more »

AMCP Nexus 2024: Specialty Drug, Biosimilar Adoption, and Health Policy Topics Highlight the Conference
American Journal of Managed Care (AJMC): The AMCP Nexus 2024 annual meeting covered a variety of hot health care topics impacting managed care pharmacy in the present and future.
Read more »